Tapewire

Nasdaq · USD

CORT

CORCEPT THERAPEUTICS INC

Export transactions ↓
Tapewire entity
2620
SEC CIK
0001088856
Parsed reports
567

Last 12 months

Inside the activity.

2 purchase rows · 107 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 2025011
Dec 202505
Jan 202601
Feb 202601
Mar 202623
Apr 202601
May 202605
Jun 2026012
Jul 2026026
Aug 2026018
Sep 2026015
Oct 202609

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 03, 2026 Filed Feb 5, 2026 22:42 UTC
Guyer WilliamChief Development Officer
Exercise / conversionStock option (right to buy) · Derivative 20,000 $0.00 Strike: $21.65 $0.00
Disclosure

SEC source: 0001193125-26-039717 · ownership.xml · derivative · entry 3

Guyer William · CIK 0001879013 · Chief Development Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 230,000

Underlying: Common Stock · 20,000 shares

Expires 2031-09-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Fully exercisable.

Read SEC document
February 03, 2026 Filed Feb 5, 2026 22:42 UTC
Guyer WilliamChief Development Officer
SaleCommon Stock 20,000 $40.87 $817,334.00
Disclosure

SEC source: 0001193125-26-039717 · ownership.xml · nonDerivative · entry 2

Guyer William · CIK 0001879013 · Chief Development Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,235

F1 · kind: This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on November 27, 2024 in effect at the time of this transaction.

F2 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $40.71 to $41.2804 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.

Read SEC document
February 03, 2026 Filed Feb 5, 2026 22:42 UTC
Guyer WilliamChief Development Officer
Exercise / conversionCommon Stock 20,000 $21.65 $433,000.00
Disclosure

SEC source: 0001193125-26-039717 · ownership.xml · nonDerivative · entry 1

Guyer William · CIK 0001879013 · Chief Development Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 21,235

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 27, 2026 Filed Jan 29, 2026 21:10 UTC Exercise / conversionStock Option (Right To Buy) · Derivative 30,000 $0.00 Strike: $15.15 $0.00
Disclosure

SEC source: 0001201715-26-000005 · form4-01292026_040101.xml · derivative · entry 12

BAKER G LEONARD JR · CIK 0001201715 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 30,000 shares

Expires 2030-05-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: Exercisable ratably in equal installments on each monthly anniversary of May 27, 2020 over one-year period.

Read SEC document
January 27, 2026 Filed Jan 29, 2026 21:10 UTC Exercise / conversionStock Option (Right To Buy) · Derivative 25,000 $0.00 Strike: $10.50 $0.00
Disclosure

SEC source: 0001201715-26-000005 · form4-01292026_040101.xml · derivative · entry 11

BAKER G LEONARD JR · CIK 0001201715 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 25,000 shares

Expires 2029-06-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: Exercisable ratably in equal installments on each monthly anniversary of June 18, 2019 over one-year period.

Read SEC document
January 27, 2026 Filed Jan 29, 2026 21:10 UTC Exercise / conversionStock Option (Right To Buy) · Derivative 25,000 $0.00 Strike: $14.08 $0.00
Disclosure

SEC source: 0001201715-26-000005 · form4-01292026_040101.xml · derivative · entry 10

BAKER G LEONARD JR · CIK 0001201715 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 25,000 shares

Expires 2028-08-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: Exercisable ratably in equal installments on each monthly anniversary of May 29, 2018 over a one-year period.

Read SEC document
January 27, 2026 Filed Jan 29, 2026 21:10 UTC Exercise / conversionStock Option (Right To Buy) · Derivative 30,000 $0.00 Strike: $12.13 $0.00
Disclosure

SEC source: 0001201715-26-000005 · form4-01292026_040101.xml · derivative · entry 9

BAKER G LEONARD JR · CIK 0001201715 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 30,000 shares

Expires 2027-05-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: Exercisable ratably in equal installments on each monthly anniversary of May 24, 2017 over one-year period.

Read SEC document
January 27, 2026 Filed Jan 29, 2026 21:10 UTC Exercise / conversionStock Option (Right To Buy) · Derivative 30,000 $0.00 Strike: $5.86 $0.00
Disclosure

SEC source: 0001201715-26-000005 · form4-01292026_040101.xml · derivative · entry 8

BAKER G LEONARD JR · CIK 0001201715 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 30,000 shares

Expires 2026-07-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Exercisable ratably on each monthly anniversary of June 27, 2016 over one-year period.

Read SEC document
January 27, 2026 Filed Jan 29, 2026 21:10 UTC Exercise / conversionCommon Stock 30,000 $15.15 $454,500.00
Disclosure

SEC source: 0001201715-26-000005 · form4-01292026_040101.xml · nonDerivative · entry 5

BAKER G LEONARD JR · CIK 0001201715 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Trust

Disclosed balance after: 1,095,262

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · ownership.nature: Shares held by a trust of which the reporting person is a trustee. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest in the trust.

Read SEC document
January 27, 2026 Filed Jan 29, 2026 21:10 UTC Exercise / conversionCommon Stock 25,000 $10.50 $262,500.00
Disclosure

SEC source: 0001201715-26-000005 · form4-01292026_040101.xml · nonDerivative · entry 4

BAKER G LEONARD JR · CIK 0001201715 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Trust

Disclosed balance after: 1,065,262

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · ownership.nature: Shares held by a trust of which the reporting person is a trustee. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest in the trust.

Read SEC document
January 27, 2026 Filed Jan 29, 2026 21:10 UTC Exercise / conversionCommon Stock 25,000 $14.08 $352,000.00
Disclosure

SEC source: 0001201715-26-000005 · form4-01292026_040101.xml · nonDerivative · entry 3

BAKER G LEONARD JR · CIK 0001201715 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Trust

Disclosed balance after: 1,040,262

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · ownership.nature: Shares held by a trust of which the reporting person is a trustee. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest in the trust.

Read SEC document
January 27, 2026 Filed Jan 29, 2026 21:10 UTC Exercise / conversionCommon Stock 30,000 $12.13 $363,900.00
Disclosure

SEC source: 0001201715-26-000005 · form4-01292026_040101.xml · nonDerivative · entry 2

BAKER G LEONARD JR · CIK 0001201715 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Trust

Disclosed balance after: 1,015,262

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · ownership.nature: Shares held by a trust of which the reporting person is a trustee. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest in the trust.

Read SEC document
January 27, 2026 Filed Jan 29, 2026 21:10 UTC Exercise / conversionCommon Stock 30,000 $5.86 $175,800.00
Disclosure

SEC source: 0001201715-26-000005 · form4-01292026_040101.xml · nonDerivative · entry 1

BAKER G LEONARD JR · CIK 0001201715 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Trust

Disclosed balance after: 985,262

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · ownership.nature: Shares held by a trust of which the reporting person is a trustee. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest in the trust.

Read SEC document
January 08, 2026 Filed Feb 13, 2026 21:25 UTC
Maduck SeanSee Remarks
OtherCommon Stock 34,000 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-051492 · ownership.xml · nonDerivative · entry 4

Maduck Sean · CIK 0001698310 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 34,000

F3 · ownership.nature: Represents the shares held by SNM 2026 Grantor Retained Annuity Trust of which the Reporting Person is the trustee.

Read SEC document
January 08, 2026 Filed Feb 13, 2026 21:25 UTC
Maduck SeanSee Remarks
GiftCommon Stock 34,000 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-051492 · ownership.xml · nonDerivative · entry 3

Maduck Sean · CIK 0001698310 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 5,147

F1 · ownership.nature: Represents the shares held by Sean and Molly Maduck Living Trust of which the Reporting Person is a co-trustee.

Read SEC document
January 08, 2026 Filed Feb 13, 2026 21:25 UTC
Maduck SeanSee Remarks
OtherCommon Stock 20,570 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-051492 · ownership.xml · nonDerivative · entry 2

Maduck Sean · CIK 0001698310 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 20,570

F2 · ownership.nature: Represents the shares held by MMM 2025, LLC of which the Reporting Person is a member and manager.

Read SEC document
January 08, 2026 Filed Feb 13, 2026 21:25 UTC
Maduck SeanSee Remarks
GiftCommon Stock 20,570 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-051492 · ownership.xml · nonDerivative · entry 1

Maduck Sean · CIK 0001698310 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 39,147

F1 · ownership.nature: Represents the shares held by Sean and Molly Maduck Living Trust of which the Reporting Person is a co-trustee.

Read SEC document
January 06, 2026 Filed Jan 9, 2026 01:35 UTC
Guyer WilliamChief Development Officer
Exercise / conversionStock option (right to buy) · Derivative 20,000 $0.00 Strike: $21.65 $0.00
Disclosure

SEC source: 0001193125-26-008023 · ownership.xml · derivative · entry 3

Guyer William · CIK 0001879013 · Chief Development Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 250,000

Underlying: Common Stock · 20,000 shares

Expires 2031-09-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Fully exercisable.

Read SEC document
January 06, 2026 Filed Jan 9, 2026 01:35 UTC
Guyer WilliamChief Development Officer
SaleCommon Stock 20,000 $35.18 $703,656.00
Disclosure

SEC source: 0001193125-26-008023 · ownership.xml · nonDerivative · entry 2

Guyer William · CIK 0001879013 · Chief Development Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,235

F1 · kind: This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on November 27, 2024 in effect at the time of this transaction.

F2 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $34.96 to $35.50 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.

Read SEC document
January 06, 2026 Filed Jan 9, 2026 01:35 UTC
Guyer WilliamChief Development Officer
Exercise / conversionCommon Stock 20,000 $21.65 $433,000.00
Disclosure

SEC source: 0001193125-26-008023 · ownership.xml · nonDerivative · entry 1

Guyer William · CIK 0001879013 · Chief Development Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 21,235

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 01, 2026 Filed Jan 5, 2026 23:11 UTC GiftCommon Stock 0 $0.00 $0.00
Disclosure

SEC source: 0001201715-26-000003 · form4-01052026_110112.xml · nonDerivative · entry 1

BAKER G LEONARD JR · CIK 0001201715 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Ltd Partnership

Disclosed balance after: 3,308,303

F1 · kind: Represents gift of limited partnership interests in a limited partnership to other limited partners. The reporting person disclaims beneficial ownership of the shares held by the limited partnership except as to the reporting person's pecuniary interest therein.

F2 · ownership.nature: Shares held by a limited partnership of which the reporting person is a trustee of a trust which is the general partner. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.

Read SEC document
December 24, 2025 Filed Dec 29, 2025 22:58 UTC
Robb Gary CharlesChief Business Officer
Exercise / conversionStock option (right to buy) · Derivative 145,000 $0.00 Strike: $3.88 $0.00
Disclosure

SEC source: 0001193125-25-335575 · ownership.xml · derivative · entry 5

Robb Gary Charles · CIK 0001529655 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 145,000 shares

Expires 2026-02-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: Fully exercisable.

Read SEC document
December 24, 2025 Filed Dec 29, 2025 22:58 UTC
Robb Gary CharlesChief Business Officer
Tax withholdingCommon Stock 80,284 $83.59 $6,710,939.56
Disclosure

SEC source: 0001193125-25-335575 · ownership.xml · nonDerivative · entry 2

Robb Gary Charles · CIK 0001529655 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 78,626

F2 · kind: These shares were withheld so the Reporting Person could satisfy the exercise price and tax liability from a net (cashless) exercise of options.

F1 · balance_after: Includes 292 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025, 997 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025, 251 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, and 224 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.

Read SEC document
December 24, 2025 Filed Dec 29, 2025 22:58 UTC
Robb Gary CharlesChief Business Officer
Exercise / conversionCommon Stock 145,000 $3.88 $562,600.00
Disclosure

SEC source: 0001193125-25-335575 · ownership.xml · nonDerivative · entry 1

Robb Gary Charles · CIK 0001529655 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 158,910

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 292 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025, 997 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025, 251 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, and 224 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.

Read SEC document
December 24, 2025 Filed Dec 29, 2025 22:24 UTC
BELANOFF JOSEPH KDirector · Chief Executive Officer
Exercise / conversionStock option (right to buy) · Derivative 550,000 $0.00 Strike: $3.88 $0.00
Disclosure

SEC source: 0001193125-25-335538 · ownership.xml · derivative · entry 5

BELANOFF JOSEPH K · CIK 0001286199 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 550,000 shares

Expires 2026-02-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: Fully exercisable.

Read SEC document
December 24, 2025 Filed Dec 29, 2025 22:24 UTC
BELANOFF JOSEPH KDirector · Chief Executive Officer
OtherCommon Stock 243,154 $0.00 $0.00
Disclosure

SEC source: 0001193125-25-335538 · ownership.xml · nonDerivative · entry 4

BELANOFF JOSEPH K · CIK 0001286199 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02

Disclosed balance after: 2,944,524

F2 · kind: Transfer of shares without consideration to the Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02.

F3 · ownership.nature: Reporting Person has voting power over the shares held by the Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02 pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein.

Read SEC document
December 24, 2025 Filed Dec 29, 2025 22:24 UTC
BELANOFF JOSEPH KDirector · Chief Executive Officer
GiftCommon Stock 243,154 $0.00 $0.00
Disclosure

SEC source: 0001193125-25-335538 · ownership.xml · nonDerivative · entry 3

BELANOFF JOSEPH K · CIK 0001286199 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Read SEC document
December 24, 2025 Filed Dec 29, 2025 22:24 UTC
BELANOFF JOSEPH KDirector · Chief Executive Officer
Tax withholdingCommon Stock 306,846 $83.59 $25,649,257.14
Disclosure

SEC source: 0001193125-25-335538 · ownership.xml · nonDerivative · entry 2

BELANOFF JOSEPH K · CIK 0001286199 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 243,154

F1 · kind: These shares were withheld so the Reporting Person could satisfy the exercise price and tax liability from a net (cashless) exercise of options.

Read SEC document
December 24, 2025 Filed Dec 29, 2025 22:24 UTC
BELANOFF JOSEPH KDirector · Chief Executive Officer
Exercise / conversionCommon Stock 550,000 $3.88 $2,134,000.00
Disclosure

SEC source: 0001193125-25-335538 · ownership.xml · nonDerivative · entry 1

BELANOFF JOSEPH K · CIK 0001286199 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 550,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 12, 2025 Filed Dec 17, 2025 02:00 UTC OtherCommon Stock 200,000 $0.00 $0.00
Disclosure

SEC source: 0001193125-25-321408 · ownership.xml · nonDerivative · entry 3

WILSON JAMES N · CIK 0001236387 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Pamela D. Wilson 2025 Grantor Retained Annuity Trust.

Disclosed balance after: 200,000

F4 · kind: Transfer of shares without consideration to Pamela D. Wilson 2025 Grantor Retained Annuity Trust.

F5 · ownership.nature: On December 12, 2025, the Reporting Person contributed 200,000 shares to a grantor retained annuity trust for the benefit of Pamela D. Wilson, the Reporting Person and her two children.

Read SEC document
December 12, 2025 Filed Dec 17, 2025 02:00 UTC OtherCommon Stock 200,000 $0.00 $0.00
Disclosure

SEC source: 0001193125-25-321408 · ownership.xml · nonDerivative · entry 2

WILSON JAMES N · CIK 0001236387 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · James N. Wilson 2025 Grantor Retained Annuity Trust.

Disclosed balance after: 200,000

F2 · kind: Transfer of shares without consideration to James N. Wilson 2025 Grantor Retained Annuity Trust.

F3 · ownership.nature: On December 12, 2025, the Reporting Person contributed 200,000 shares to a grantor retained annuity trust for the benefit of himself, Pamela D. Wilson and his two children.

Read SEC document
December 12, 2025 Filed Dec 17, 2025 02:00 UTC GiftCommon Stock 400,000 $0.00 $0.00
Disclosure

SEC source: 0001193125-25-321408 · ownership.xml · nonDerivative · entry 1

WILSON JAMES N · CIK 0001236387 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · James N. Wilson and Pamela D. Wilson Trust

Disclosed balance after: 1,045,168

F1 · ownership.nature: Reporting Person has voting power over the shares held by the James N. Wilson and Pamela D. Wilson Trust and James and Pamela Wilson Family Partners pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein.

Read SEC document
December 02, 2025 Filed Dec 4, 2025 02:19 UTC
Guyer WilliamChief Development Officer
Exercise / conversionStock option (right to buy) · Derivative 20,000 $0.00 Strike: $21.65 $0.00
Disclosure

SEC source: 0001193125-25-307282 · ownership.xml · derivative · entry 8

Guyer William · CIK 0001879013 · Chief Development Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 270,000

Underlying: Common Stock · 20,000 shares

Expires 2031-09-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · derivative.exercise_date: Fully exercisable.

Read SEC document
December 02, 2025 Filed Dec 4, 2025 02:19 UTC
Guyer WilliamChief Development Officer
SaleCommon Stock 640 $80.88 $51,760.00
Disclosure

SEC source: 0001193125-25-307282 · ownership.xml · nonDerivative · entry 7

Guyer William · CIK 0001879013 · Chief Development Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,235

F6 · kind: This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on November 27, 2024 in effect at the time of this transaction.

Read SEC document
December 02, 2025 Filed Dec 4, 2025 02:19 UTC
Guyer WilliamChief Development Officer
SaleCommon Stock 19,360 $80.05 $1,549,766.06
Disclosure

SEC source: 0001193125-25-307282 · ownership.xml · nonDerivative · entry 6

Guyer William · CIK 0001879013 · Chief Development Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,875

F6 · kind: This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on November 27, 2024 in effect at the time of this transaction.

F7 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $79.78 to $80.68 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.

Read SEC document
December 02, 2025 Filed Dec 4, 2025 02:19 UTC
Guyer WilliamChief Development Officer
Exercise / conversionCommon Stock 20,000 $21.65 $433,000.00
Disclosure

SEC source: 0001193125-25-307282 · ownership.xml · nonDerivative · entry 5

Guyer William · CIK 0001879013 · Chief Development Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 21,235

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 02, 2025 Filed Dec 4, 2025 02:19 UTC
Guyer WilliamChief Development Officer
OtherCommon Stock 787 $0.00 $0.00
Disclosure

SEC source: 0001193125-25-307282 · ownership.xml · nonDerivative · entry 4

Guyer William · CIK 0001879013 · Chief Development Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,235

F5 · kind: Transfer of shares without consideration to the Reporting Person.

Read SEC document
December 02, 2025 Filed Dec 4, 2025 02:19 UTC
Guyer WilliamChief Development Officer
GiftCommon Stock 787 $0.00 $0.00
Disclosure

SEC source: 0001193125-25-307282 · ownership.xml · nonDerivative · entry 3

Guyer William · CIK 0001879013 · Chief Development Officer

10b5-1 filing: Plan reported

Ownership: Indirect · The Lake Bainwood Living Trust

Disclosed balance after: 0

F4 · ownership.nature: Represents the shares held by The Lake Bainwood Living Trust of which the Reporting Person is a co-trustee.

Read SEC document
December 02, 2025 Filed Dec 4, 2025 01:53 UTC
Maduck SeanSee Remarks
Tax withholdingCommon Stock 135 $79.78 $10,770.30
Disclosure

SEC source: 0001193125-25-307251 · ownership.xml · nonDerivative · entry 5

Maduck Sean · CIK 0001698310 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,179

F7 · kind: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units.

F8 · price: The closing price on December 1, 2025 was used to calculate the withholding obligation.

F1 · balance_after: Includes 266 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025, 888 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025 and 228 underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.

Read SEC document
December 02, 2025 Filed Dec 4, 2025 01:36 UTC Tax withholdingCommon Stock 110 $79.78 $8,775.80
Disclosure

SEC source: 0001193125-25-307229 · ownership.xml · nonDerivative · entry 5

Lyon Joseph Douglas · CIK 0001817838 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 10,523

F7 · kind: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units.

F8 · price: The closing price on December 1, 2025 was used to calculate the withholding obligation.

F1 · balance_after: Includes 216 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025, 749 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025 and 200 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.

Read SEC document
December 02, 2025 Filed Dec 4, 2025 01:25 UTC
Mokari AtabakChief Financial Officer
Tax withholdingCommon Stock 118 $79.78 $9,414.04
Disclosure

SEC source: 0001193125-25-307218 · ownership.xml · nonDerivative · entry 3

Mokari Atabak · CIK 0001678419 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,559

F5 · kind: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units.

F6 · price: The closing price on December 1, 2025 was used to calculate the withholding obligation.

F3 · balance_after: Includes 232 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025, 775 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025 and 200 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.

Read SEC document
December 02, 2025 Filed Dec 4, 2025 01:22 UTC
Robb Gary CharlesChief Business Officer
Tax withholdingCommon Stock 148 $79.78 $11,807.44
Disclosure

SEC source: 0001193125-25-307213 · ownership.xml · nonDerivative · entry 3

Robb Gary Charles · CIK 0001529655 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,910

F5 · kind: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units.

F6 · price: The closing price on December 1, 2025 was used to calculate the withholding obligation.

F3 · balance_after: Includes 292 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025, 997 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025 and 251 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.

Read SEC document
December 01, 2025 Filed Dec 4, 2025 02:19 UTC
Guyer WilliamChief Development Officer
GrantCommon Stock 224 $0.00 $0.00
Disclosure

SEC source: 0001193125-25-307282 · ownership.xml · nonDerivative · entry 2

Guyer William · CIK 0001879013 · Chief Development Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 448

F3 · shares: Shares underlie unvested restricted stock awards granted to the Reporting Person by the Issuer under the Purchase Plan. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person remains the beneficial owner of the Purchase Plan Shares through such one-year anniversary.

Read SEC document
December 01, 2025 Filed Dec 4, 2025 02:19 UTC
Guyer WilliamChief Development Officer
GrantCommon Stock 224 $79.78 $17,870.72
Disclosure

SEC source: 0001193125-25-307282 · ownership.xml · nonDerivative · entry 1

Guyer William · CIK 0001879013 · Chief Development Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 224

F1 · shares: The Reporting Person purchased shares ("Purchase Plan Shares") of the Issuer's common stock pursuant to a purchase plan ("Purchase Plan") established under the Corcept Therapeutics Incorporated 2024 Incentive Award Plan on December 1, 2025.

F2 · price: In accordance with the Purchase Plan, the price was established based on the closing price on the day of the purchase.

Read SEC document
December 01, 2025 Filed Dec 4, 2025 01:53 UTC
Maduck SeanSee Remarks
Exercise / conversionStock option (right to buy) · Derivative 20,000 $0.00 Strike: $8.27 $0.00
Disclosure

SEC source: 0001193125-25-307251 · ownership.xml · derivative · entry 9

Maduck Sean · CIK 0001698310 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 241,986

Underlying: Common Stock · 20,000 shares

Expires 2027-02-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F12 · derivative.exercise_date: Fully exercisable.

Read SEC document
December 01, 2025 Filed Dec 4, 2025 01:53 UTC
Maduck SeanSee Remarks
GrantCommon Stock 205 $0.00 $0.00
Disclosure

SEC source: 0001193125-25-307251 · ownership.xml · nonDerivative · entry 4

Maduck Sean · CIK 0001698310 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,314

F6 · shares: Shares underlie unvested restricted stock awards granted to the Reporting Person by the Issuer under the Purchase Plan. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person remains the beneficial owner of the Purchase Plan Shares through such one-year anniversary.

F1 · balance_after: Includes 266 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025, 888 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025 and 228 underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.

Read SEC document
December 01, 2025 Filed Dec 4, 2025 01:53 UTC
Maduck SeanSee Remarks
GrantCommon Stock 205 $79.78 $16,354.90
Disclosure

SEC source: 0001193125-25-307251 · ownership.xml · nonDerivative · entry 3

Maduck Sean · CIK 0001698310 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,109

F4 · shares: The Reporting Person purchased shares ("Purchase Plan Shares") of the Issuer's common stock pursuant to a purchase plan ("Purchase Plan") established under the Corcept Therapeutics Incorporated 2024 Incentive Award Plan on December 1, 2025.

F5 · price: In accordance with the Purchase Plan, the price was established based on the closing price on the day of the purchase.

F1 · balance_after: Includes 266 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025, 888 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025 and 228 underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.

Read SEC document
December 01, 2025 Filed Dec 4, 2025 01:53 UTC
Maduck SeanSee Remarks
SaleCommon Stock 20,000 $79.52 $1,590,490.00
Disclosure

SEC source: 0001193125-25-307251 · ownership.xml · nonDerivative · entry 2

Maduck Sean · CIK 0001698310 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 7,904

F2 · kind: This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on September 5, 2024 in effect at the time of this transaction.

F3 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $79.40 to $79.81 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.

F1 · balance_after: Includes 266 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025, 888 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025 and 228 underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.

Read SEC document
December 01, 2025 Filed Dec 4, 2025 01:53 UTC
Maduck SeanSee Remarks
Exercise / conversionCommon Stock 20,000 $8.27 $165,400.00
Disclosure

SEC source: 0001193125-25-307251 · ownership.xml · nonDerivative · entry 1

Maduck Sean · CIK 0001698310 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 27,904

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 266 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025, 888 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025 and 228 underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.

Read SEC document
December 01, 2025 Filed Dec 4, 2025 01:36 UTC Exercise / conversionStock option (right to buy) · Derivative 5,000 $0.00 Strike: $13.56 $0.00
Disclosure

SEC source: 0001193125-25-307229 · ownership.xml · derivative · entry 6

Lyon Joseph Douglas · CIK 0001817838 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 11,571

Underlying: Common Stock · 5,000 shares

Expires 2030-02-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F9 · derivative.exercise_date: Fully exercisable.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.